RATIOS
Balaxi Pharmaceuticals Ltd.
NSE
Jul 04
49.35
+0.48 (+ 0.98%)
Volume
156533
Prev. Close
48.87
Open Price
49.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
|
ISIN No
|
INE618N01022
|
Market Cap. ( ₹ in Cr. )
|
272.45
|
P/BV
|
1.26
|
Book Value ( ₹ )
|
39.10
|
|
BSE Code
|
-
|
52 Week High/Low ( ₹ )
|
129/49
|
FV/ML
|
2/1
|
P/E(X)
|
10.87
|
|
NSE Code
|
BALAXIEQ
|
Book Closure
|
30/05/2024
|
EPS ( ₹ )
|
4.54
|
Div Yield (%)
|
0.00
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.65 | 3.55 | 16.17 | 14.67 | 15.13 |
| Diluted EPS (Rs.) | 0.65 | 3.54 | 16.02 | 14.67 | 15.13 |
| Cash EPS (Rs.) | 0.73 | 3.82 | 16.44 | 14.92 | 15.22 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 23.16 | 111.53 | 90.47 | 57.91 | 43.24 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 23.16 | 111.53 | 90.47 | 57.91 | 43.24 |
| Revenue From Operations / Share (Rs.) | 11.05 | 64.41 | 106.21 | 101.29 | 86.87 |
| PBDIT / Share (Rs.) | 1.41 | 7.00 | 23.01 | 20.01 | 20.70 |
| PBIT / Share (Rs.) | 1.33 | 6.54 | 22.50 | 19.76 | 20.61 |
| PBT / Share (Rs.) | 0.95 | 5.12 | 22.05 | 19.70 | 20.60 |
| Net Profit / Share (Rs.) | 0.65 | 3.35 | 15.93 | 14.67 | 15.13 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 12.79 | 10.87 | 21.66 | 19.75 | 23.82 |
| PBIT Margin (%) | 12.04 | 10.14 | 21.18 | 19.50 | 23.72 |
| PBT Margin (%) | 8.67 | 7.95 | 20.76 | 19.44 | 23.70 |
| Net Profit Margin (%) | 5.90 | 5.20 | 15.00 | 14.48 | 17.42 |
| Return on Networth / Equity (%) | 2.81 | 3.00 | 17.61 | 25.32 | 34.99 |
| Return on Capital Employeed (%) | 5.62 | 5.73 | 24.14 | 34.09 | 47.64 |
| Return On Assets (%) | 2.06 | 2.36 | 12.50 | 17.90 | 21.95 |
| Total Debt / Equity (X) | 0.23 | 0.11 | 0.11 | 0.03 | 0.08 |
| Asset Turnover Ratio (%) | 0.37 | 0.49 | 1.02 | 1.34 | 1.63 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.73 | 4.09 | 2.84 | 2.26 | 1.90 |
| Quick Ratio (X) | 2.73 | 4.06 | 2.80 | 2.26 | 1.90 |
| Inventory Turnover Ratio (X) | 121.33 | 48.40 | 0.00 | 10255.89 | 149.52 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 3.08 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 2.98 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 96.92 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 97.02 | 0.00 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 3.79 | 4.95 | 51.03 | 326.96 | 1579.95 |
| Interest Coverage Ratio (Post Tax) (%) | 2.75 | 3.37 | 36.34 | 240.66 | 1156.22 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 354.58 | 510.37 | 532.84 | 352.69 | 527.53 |
| EV / Net Operating Revenue (X) | 5.81 | 7.27 | 4.93 | 3.48 | 6.07 |
| EV / EBITDA (X) | 45.45 | 66.85 | 22.75 | 17.63 | 25.49 |
| MarketCap / Net Operating Revenue (X) | 5.79 | 7.70 | 4.99 | 3.47 | 6.04 |
| Retention Ratios (%) | 0.00 | 0.00 | 96.91 | 0.00 | 0.00 |
| Price / BV (X) | 2.76 | 4.45 | 5.86 | 6.07 | 12.13 |
| Price / Net Operating Revenue (X) | 5.79 | 7.70 | 4.99 | 3.47 | 6.04 |
| EarningsYield | 0.01 | 0.01 | 0.03 | 0.04 | 0.02 |